Pharmacogenomic polygenic risk score for clopidogrel responsiveness among Caribbean Hispanics: A candidate gene approach
Abstract This multicenter clinical study was aimed at conducting a targeted pharmacogenomic association analysis of residual on‐clopidogrel platelet reactivity in 474 Caribbean Hispanic patients. Platelet reactivity was measured using the VerifyNow P2Y12 assay and clopidogrel resistance was defined...
Guardado en:
Autores principales: | Jorge Duconge, Ednalise Santiago, Dagmar F. Hernandez‐Suarez, Mariangeli Moneró, Andrés López‐Reyes, Marines Rosario, Jessicca Y. Renta, Pablo González, Laura Ileana Fernández‐Morales, Luis Antonio Vélez‐Figueroa, Orlando Arce, Frances Marín‐Maldonado, Héctor Nuñez, Kyle Melin, Stuart A. Scott, Gualberto Ruaño |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/be462ad7effa4eb8aab47ac60bdf0e94 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The pharmacogenomics journal
Publicado: (2001) -
Pharmacogenomics and Personalized Medicine
Publicado: (2009) -
Chapter 7: Pharmacogenomics.
por: Konrad J Karczewski, et al.
Publicado: (2012) -
Pharmacogenomics of hyaluronic acid
por: Elena E. Vaiman, et al.
Publicado: (2021) -
Pharmacogenomics and Rheumatological Practice
por: Chuanhui Xu, et al.
Publicado: (2021)